- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Paclitaxel
Total 4008 results
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, South Africa
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Cancer | Vaginal CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
European Organisation for Research and Treatment...CompletedVulvar CancerItaly, France, Netherlands, Belgium, United Kingdom, Portugal
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
TheradexUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
Duke UniversityCelgene CorporationTerminatedMetastatic Breast CancerUnited States, China
-
Yale UniversityAgennixCompletedAdvanced CancersUnited States
-
Genoss Co., Ltd.CompletedCoronary Artery DiseaseKorea, Republic of
-
Indiana UniversityCompletedPancreatic Cyst | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Cystadenoma, Mucinous | Papillary Mucinous Cystadenoma, Borderline MalignancyUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
University of UtahCelgene CorporationCompletedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Breast CancerUnited States
-
University of UtahRecruitingNon Small Cell Lung CancerUnited States
-
Atlantic Health SystemCornerstone PharmaceuticalsUnknownPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
Chinese PLA General HospitalUnknownAdvanced Pancreatic CancerChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedSarcomaUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Mary Babb Randolph Cancer Center at West Virginia...Completed
-
European Organisation for Research and Treatment...CompletedEndometrial CancerBelgium, Austria, United Kingdom, Portugal, Italy, Spain
-
TheradexUnknownEsophageal CancerUnited States
-
Korean Gynecologic Oncology GroupUnknownEndometrial CancerKorea, Republic of
-
Shanghai Yizhong Pharmaceutical Co., Ltd.RecruitingMetastatic Breast Cancer (MBC)China
-
Chinese PLA General HospitalRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreas Cancer | PDAC - Pancreatic Ductal AdenocarcinomaChina
-
Japanese Foundation for Cancer ResearchChugai PharmaceuticalActive, not recruiting
-
Osaka Medical Center for Cancer and Cardiovascular...CompletedPancreatic CancerJapan
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Second Affiliated Hospital, School of Medicine,...RecruitingOvarian Cancer | Neoadjuvant Chemotherapy | Anti-PD-1 | Neoadjuvant ImmunotherapyChina
-
Huazhong University of Science and TechnologyCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Recurrent Cervical Carcinoma | Cervical Small Cell CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
Juan LI, MDRecruitingStage III Non-small Cell Lung CancerChina
-
NovoCure Ltd.CompletedOvarian CancerUnited States, Israel, Belgium, Netherlands, Hungary, Germany, Poland, Canada, Austria, Czechia, Italy, Spain, Switzerland
-
Hoffmann-La RocheCompleted
-
Actuate Therapeutics Inc.Active, not recruitingSarcoma | Cancer | Breast Neoplasms | Neoplasm Metastasis | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Bone Cancer | Malignant Glioma | Bone Metastases | Pancreas Cancer | Renal Cancer | Refractory Non-Hodgkin Lymphoma | Bone Neoplasm | Neoplasm, Breast | Refractory Cancer | Refractory Neoplasm | Resistant... and other conditionsUnited States, Belgium, Canada, Spain, France, Netherlands, Portugal
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of ChicagoCompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdRecruitingTriple Negative Breast Cancer (TNBC)China
-
Tianjin Medical University Second HospitalRecruitingMuscle Invasive Bladder Cancer Urothelial CarcinomaChina
-
Adlai Nortye Biopharma Co., Ltd.Active, not recruitingHead and Neck CancerUnited States, United Kingdom, France, Hungary, Spain, Japan, Italy, Hong Kong, Taiwan, Korea, Republic of, Germany, Australia, China, Canada, Belgium, Argentina, Poland
-
Spanish Breast Cancer Research GroupCelgeneCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyWithdrawnEsophageal Squamous Cell Carcinoma
-
Translational Research in OncologyStand Up To Cancer; Effector TherapeuticsCompleted